Authorization

Biofourmis' AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore

BOSTON andA SINGAPORE, July 29, 2020 /PRNewswire/ -- and July 30, 2020 a?? Biofourmis , a global leader in digital therapeutics that powers personalized predictive care, announced today that its BiovitalsA® Sentinel platform has been deployed by the Ministry of Health (MOH) in Singapore to remotely monitor COVID-19-positive patients to aid in early detection of deterioration and to enable clinicians and nurse teams to intervene early.
Biofourmis' AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore
MOH has set up community care facilities (CCF) to care for COVID-19 patients who are clinically well and no longer require acute care, and newly confirmed cases with mild symptoms that do not require hospital care. Biofourmis worked with MOH and the healthcare providers at the CCF at Singapore EXPO & MAX Atria and several Swab Isolation Facilities (SIF)a??where patients awaiting swab results are isolateda??to demonstrate the use of BiovitalsA® Sentinel to augment patient care for individuals housed at these facilities, with real-time remote vital sign monitoring by clinicians and nurse teams. BiovitalsA® Sentinel is a turn-key solution powered by Biofourmis' industry-leading artificial intelligence (AI)-powered BiovitalsA® Platform. Its 24/7 remote monitoring technology and analytics are providing clinicians with real-time vital signs and symptoms for early identification of any physiological changes that could indicate deterioration, and to enable earlier interventions for better outcomes. [To download a photo of the BiovitalsA® Sentinel platform, click here.]Scaling up implementation to wider coverage
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2023    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
3031